Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine + bupivacaine versus bupivacaine alone for supraclavicular block
IRCT20250506065621N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in None comparing Lidocaine + bupivacaine with Bupivacaine alone (2 arms). Primary endpoints: Time from start of sensory block to return of limb sensation, Time from start of motor block to return of limb movement and 2 more. Started Jun 2025; status: completed.
02
Drugs
lidocainebupivacaine
Beyond the preview
Go deeper on IRCT20250506065621N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250506065621N1.